Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765544 · ClinicalTrials.gov registry record · Phase 1
Targeted Lower Extremity Joint Training
A Phase 1 study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00765544 is a Phase 1 study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 10 participants.
The verdict
NCT00765544, a Phase 1 study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The presence of foot drop limits normal gait. Our prior data has suggested that approximately 30% of MS patients have foot drop. Although we have observed that "task-specific" rehabilitation using the Lokomat can improve ambulation in chronic MS patients, subjects with "foot drop" have difficulty translating task-specific training to normative gait patterns over ground, despite improving speed and endurance. One of the key limitations of the Lokomat is a lack of robot-assisted training for the ankle joint. The Anklebot, an MIT-developed rehabilitation robot for the ankle, has the potential to address this. The device can move throughout three planes and train ankle flexion, extension, inversion and eversion; however, therapy with the Anklebot alone does not train the knee or hip. We plan to test whether subject foot drop and overall gait benefit more from Anklebot therapy alone or a combination of Anklebot and Lokomat.
Interventions
- DEVICE Lokomat
- DEVICE Anklebot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00765544
The ClinicalTrials.gov registry entry for NCT00765544 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lokomat is the first listed.
NCT00765544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00765544 about?
NCT00765544 is a clinical study titled "Targeted Lower Extremity Joint Training". The presence of foot drop limits normal gait. Our prior data has suggested that approximately 30% of MS patients have foot drop. Although we have observed that "task-specific" rehabilitation using the Lokomat can improve ambulation in chronic MS patients, subjects with "foot drop" have difficulty tr...
What is the current status of trial NCT00765544?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2008-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00765544?
The interventions under investigation include: Lokomat (DEVICE), Anklebot (DEVICE).
Who is sponsoring clinical trial NCT00765544?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.